Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma

A review and consensus statement

K. Raj Prasad, Richard S. Young, Patrizia Burra, Shu Sen Zheng, Vincenzo Mazzaferro, Duk Bog Moon, Richard B. Freeman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The evidence base is poor overall because of the limitedsample sizes of most studies and the heterogeneouscohorts and variables, and few have well-plannedand statistically valid study designs. No studies haveaccounted for the effects of underlying liver diseaseseither before or after LT on overall outcomes, and onlya few studies have assessed the effects of adjuvanttreatments before transplantation. In the majority ofthe reports, the follow-up time is not sufficient forassessing 5-year survival rates. Many have used histologicalfindings from explanted livers to stagepatients, but this has little utility for preoperativestaging and selection for LT. The presence of vascularinvasion, the tumor number and size (also calculatedas the TTV), and the AFP level have most consistentlybeen associated with increased recurrence rates anddiminished survival after LT. Most studies havereported acceptable survival rates for patients meetingthe UCSF criteria; however, it is notable that there aredocumented survival rates for patients with HCCtumors beyond the UCSF criteria that would bemore than acceptable in any other surgicaloncology setting. It is the potential to affect candidateswithout HCC who are also competing for thelimited pool of donor organs that limits the criteria forselecting patients with HCC for LT, especially whenwe consider LT for patients with more advancedstages of HCC.

Original languageEnglish
JournalLiver Transplantation
Volume17
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Liver Transplantation
Patient Selection
Hepatocellular Carcinoma
Survival Rate
Liver
Transplantation
Tissue Donors
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Transplantation
  • Hepatology

Cite this

Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma : A review and consensus statement. / Prasad, K. Raj; Young, Richard S.; Burra, Patrizia; Zheng, Shu Sen; Mazzaferro, Vincenzo; Bog Moon, Duk; Freeman, Richard B.

In: Liver Transplantation, Vol. 17, No. SUPPL. 2, 10.2011.

Research output: Contribution to journalArticle

Prasad, K. Raj ; Young, Richard S. ; Burra, Patrizia ; Zheng, Shu Sen ; Mazzaferro, Vincenzo ; Bog Moon, Duk ; Freeman, Richard B. / Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma : A review and consensus statement. In: Liver Transplantation. 2011 ; Vol. 17, No. SUPPL. 2.
@article{b1ad0e77295a49b8bd66783b44b230c8,
title = "Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement",
abstract = "The evidence base is poor overall because of the limitedsample sizes of most studies and the heterogeneouscohorts and variables, and few have well-plannedand statistically valid study designs. No studies haveaccounted for the effects of underlying liver diseaseseither before or after LT on overall outcomes, and onlya few studies have assessed the effects of adjuvanttreatments before transplantation. In the majority ofthe reports, the follow-up time is not sufficient forassessing 5-year survival rates. Many have used histologicalfindings from explanted livers to stagepatients, but this has little utility for preoperativestaging and selection for LT. The presence of vascularinvasion, the tumor number and size (also calculatedas the TTV), and the AFP level have most consistentlybeen associated with increased recurrence rates anddiminished survival after LT. Most studies havereported acceptable survival rates for patients meetingthe UCSF criteria; however, it is notable that there aredocumented survival rates for patients with HCCtumors beyond the UCSF criteria that would bemore than acceptable in any other surgicaloncology setting. It is the potential to affect candidateswithout HCC who are also competing for thelimited pool of donor organs that limits the criteria forselecting patients with HCC for LT, especially whenwe consider LT for patients with more advancedstages of HCC.",
author = "Prasad, {K. Raj} and Young, {Richard S.} and Patrizia Burra and Zheng, {Shu Sen} and Vincenzo Mazzaferro and {Bog Moon}, Duk and Freeman, {Richard B.}",
year = "2011",
month = "10",
doi = "10.1002/lt.22380",
language = "English",
volume = "17",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma

T2 - A review and consensus statement

AU - Prasad, K. Raj

AU - Young, Richard S.

AU - Burra, Patrizia

AU - Zheng, Shu Sen

AU - Mazzaferro, Vincenzo

AU - Bog Moon, Duk

AU - Freeman, Richard B.

PY - 2011/10

Y1 - 2011/10

N2 - The evidence base is poor overall because of the limitedsample sizes of most studies and the heterogeneouscohorts and variables, and few have well-plannedand statistically valid study designs. No studies haveaccounted for the effects of underlying liver diseaseseither before or after LT on overall outcomes, and onlya few studies have assessed the effects of adjuvanttreatments before transplantation. In the majority ofthe reports, the follow-up time is not sufficient forassessing 5-year survival rates. Many have used histologicalfindings from explanted livers to stagepatients, but this has little utility for preoperativestaging and selection for LT. The presence of vascularinvasion, the tumor number and size (also calculatedas the TTV), and the AFP level have most consistentlybeen associated with increased recurrence rates anddiminished survival after LT. Most studies havereported acceptable survival rates for patients meetingthe UCSF criteria; however, it is notable that there aredocumented survival rates for patients with HCCtumors beyond the UCSF criteria that would bemore than acceptable in any other surgicaloncology setting. It is the potential to affect candidateswithout HCC who are also competing for thelimited pool of donor organs that limits the criteria forselecting patients with HCC for LT, especially whenwe consider LT for patients with more advancedstages of HCC.

AB - The evidence base is poor overall because of the limitedsample sizes of most studies and the heterogeneouscohorts and variables, and few have well-plannedand statistically valid study designs. No studies haveaccounted for the effects of underlying liver diseaseseither before or after LT on overall outcomes, and onlya few studies have assessed the effects of adjuvanttreatments before transplantation. In the majority ofthe reports, the follow-up time is not sufficient forassessing 5-year survival rates. Many have used histologicalfindings from explanted livers to stagepatients, but this has little utility for preoperativestaging and selection for LT. The presence of vascularinvasion, the tumor number and size (also calculatedas the TTV), and the AFP level have most consistentlybeen associated with increased recurrence rates anddiminished survival after LT. Most studies havereported acceptable survival rates for patients meetingthe UCSF criteria; however, it is notable that there aredocumented survival rates for patients with HCCtumors beyond the UCSF criteria that would bemore than acceptable in any other surgicaloncology setting. It is the potential to affect candidateswithout HCC who are also competing for thelimited pool of donor organs that limits the criteria forselecting patients with HCC for LT, especially whenwe consider LT for patients with more advancedstages of HCC.

UR - http://www.scopus.com/inward/record.url?scp=80053267175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053267175&partnerID=8YFLogxK

U2 - 10.1002/lt.22380

DO - 10.1002/lt.22380

M3 - Article

VL - 17

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - SUPPL. 2

ER -